Table 6.
Natural killer cell and antigen-presenting cell populations of dogs supplemented with a yeast fermentation product
Saccharomyces cerevisiae fermentation product, mg/d | P-value | |||||||
---|---|---|---|---|---|---|---|---|
Item | 0 | 125 | 250 | 500 | SEM | Linear | Quadratic | 0 vs. yeast |
Natural killer cell, % of lymphocyte | 14.34 | 10.52 | 10.27 | 12.55 | 3.07 | 0.39 | 0.12 | 0.11 |
Antigen-presenting cells | ||||||||
B cell, % of lymphocyte | 8.08 | 7.35 | 9.37 | 7.96 | 2.51 | 0.44 | 0.86 | 0.85 |
B cell, MHC II+, % of B cell1 | 96.26 | 97.20 | 97.44 | 97.25 | 1.56 | 0.12 | 0.29 | 0.05 |
Monocyte, % of white blood cell | 4.16 | 4.29 | 4.77 | 3.99 | 2.37 | 0.81 | 0.95 | 0.73 |
Monocyte, MHC II+, % of monocyte1 | 55.90 | 51.18 | 59.04 | 61.33 | 7.63 | 0.86 | 0.68 | 0.05 |
1B cells or monocytes that present major histocompatibility complex class II (MHC II).